J0208 Injection, pedmark, 100 milligrams
J-Codes
Also known as: amifostine mesylate, Pedmark
Amifostine mesylate (Pedmark) injection 100 milligrams, a cytoprotective agent for cisplatin ototoxicity.
Clinical Context
Intravenous amifostine formulation (Pedmark) specifically for reducing cisplatin-related ototoxicity (hearing loss) in pediatric patients with cancer.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.